Cargando…

Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder

OBJECTIVE: This study evaluated the treatment outcomes of agomelatine on anhedonic state, anxiety/somatic symptoms, and sexual function in Chinese patients with major depressive disorder (MDD). METHOD: In total, 93 adult patients with MDD were enrolled, and 68 of them were included in a prospective,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Juan, Xie, Xiao-Meng, Lyu, Nan, Fu, Bing-Bing, Zhao, Qian, Zhang, Ling, Wang, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157485/ https://www.ncbi.nlm.nih.gov/pubmed/37151978 http://dx.doi.org/10.3389/fpsyt.2023.1115008

Ejemplares similares

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

Dysfunctional Attitudes Mediate the Relationship Between Childhood Emotional Neglect and Anhedonia in Young Adult Major Depression Patients
por: Wang, Peilin, et al.
Publicado: (2022)

Multimodal Investigations of Reward Circuitry and Anhedonia in Adolescent Depression
por: Ely, Benjamin A., et al.
Publicado: (2021)

Somatization Symptoms Regulate Emotional Memory Bias in Adolescents With Major Depressive Disorder
por: Daming, Mo, et al.
Publicado: (2021)

The role of leptin in indirectly mediating “somatic anxiety” symptoms in major depressive disorder
por: Zhu, Yue, et al.
Publicado: (2022)

Increased plasma levels of IL-6 are associated with striatal structural atrophy in major depressive disorder patients with anhedonia
por: Lu, Shaojia, et al.
Publicado: (2022)

A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine
por: Li, Zhe, et al.
Publicado: (2023)

Predictive potential of somatic symptoms for the identification of subthreshold depression and major depressive disorder in primary care settings
por: Li, Xiuwen, et al.
Publicado: (2023)

A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD)
por: Guo, Ping, et al.
Publicado: (2023)

Gender specific sexual dysfunction in patients with depression
por: Liu, Xinyu, et al.
Publicado: (2023)

Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study Protocol
por: Bilderbeck, Amy C., et al.
Publicado: (2020)

The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Zhu, Yue, et al.
Publicado: (2019)

Exploring Brain Derived Neurotrophic Factor and Cell Adhesion Molecules as Biomarkers for the Transdiagnostic Symptom Anhedonia in Alcohol Use Disorder and Comorbid Depression
por: Levchuk, Lyudmila A., et al.
Publicado: (2020)

The Heterogeneity of Empathy: Possible Treatment for Anhedonia?
por: Light, Sharee N.
Publicado: (2019)

A Transdiagnostic Perspective on Social Anhedonia
por: Barkus, Emma, et al.
Publicado: (2019)

Depression and Somatic Symptoms in a Non-Western Physician
por: Oh, Philip, et al.
Publicado: (2021)

Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders
por: Liu, Yi, et al.
Publicado: (2019)

Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2023)

Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model
por: Yardimci, Ahmet, et al.
Publicado: (2021)

Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitive Transcranial Magnetic Stimulation
por: Elemery, Monika, et al.
Publicado: (2022)

Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis
por: Wu, Xiaohui, et al.
Publicado: (2022)

Agomelatine's antiglycoxidative action—In vitro and in silico research and systematic literature review
por: Nesterowicz, Miłosz, et al.
Publicado: (2023)

A Preliminary Study of White Matter in Adolescent Depression: Relationships with Illness Severity, Anhedonia, and Irritability
por: Henderson, Sarah E., et al.
Publicado: (2013)

Association of Cognitive Impairment With Anhedonia in Patients With Schizophrenia
por: Yu, Lingfang, et al.
Publicado: (2021)

Simulating the anhedonia symptom of depression in animals
por: Moreau, Jean-Luc
Publicado: (2002)

Anhedonia. Depressive versus negative symptom
por: Reynolds De Sousa, T., et al.
Publicado: (2022)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
por: Gahr, Maximilian
Publicado: (2014)

Correlation Analysis Between Attentional Bias and Somatic Symptoms in Depressive Disorders
por: Wang, Yun, et al.
Publicado: (2019)

Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
por: Hatzigiakoumis, Daniele Stavros, et al.
Publicado: (2011)

Anhedonia in schizophrenia and major depression: state or trait?
por: Pelizza, Lorenzo, et al.
Publicado: (2009)

Corrigendum: Correlation Analysis Between Attentional Bias and Somatic Symptoms in Depressive Disorders
por: Wang, Yun, et al.
Publicado: (2020)

Addiction, Anhedonia, and Comorbid Mood Disorder. A Narrative Review
por: Destoop, Marianne, et al.
Publicado: (2019)

Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H
por: Zhang, Yi, et al.
Publicado: (2023)

Editorial: Brain and Somatization Symptoms in Psychiatric Disorders
por: Fu, Xiaoya, et al.
Publicado: (2019)

Behavioral Inhibition/Activation Systems and Depression Among Females With Substance Use Disorder: The Mediating Role of Intolerance of Uncertainty and Anhedonia
por: Xie, Jinlan, et al.
Publicado: (2021)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

Parallel Changes in Mood and Melatonin Rhythm Following an Adjunctive Multimodal Chronobiological Intervention With Agomelatine in People With Depression: A Proof of Concept Open Label Study
por: Robillard, Rebecca, et al.
Publicado: (2018)

Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder
por: Zuckerman, Hannah, et al.
Publicado: (2018)

Gender Differences in Dysfunctional Attitudes in Major Depressive Disorder
por: Qin, Xuemei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nmo7vq3cig72paqqe3uc4jehra